orphenadrine has been researched along with Leukemia, Myeloid in 1 studies
Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedman, GD | 1 |
1 other study available for orphenadrine and Leukemia, Myeloid
| Article | Year |
|---|---|
Phenylbutazone, musculoskeletal disease, and leukemia.
Topics: Acetaminophen; Adrenal Cortex Hormones; Adult; Aged; Bone Diseases; Delivery of Health Care; Diazepa | 1982 |